Comparison 4. Exenatide 2 mg once weekly versus insulin glargine.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 HbA1c (%)	1		Mean Difference (IV, Fixed, 95% CI)	Subtotals only
2 HbA1c < 7%	1		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
3 Hypoglycaemia (symptoms only)	1		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
4 Hypoglycaemia (minor)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
5 Severe hypoglycaemia			Other data	No numeric data
6 Weight change (kg)	1		Mean Difference (IV, Fixed, 95% CI)	Subtotals only
7 Adverse events			Other data	No numeric data
8 Quality of life			Other data	No numeric data
9 Fasting plasma glucose (mmol/L)	1		Mean Difference (IV, Fixed, 95% CI)	Subtotals only
10 Postprandial glucose / glucose profiles			Other data	No numeric data